Set Patient Expectations for Home Genetic Tests

July 2018

Patients will ask you about direct-to-consumer genetic tests for diseases...now that FDA allows marketing of 23andMe genetic risk tests.

The 23andMe tests analyze specific gene markers linked to conditions such as Alzheimer's, breast cancer, celiac disease, and Parkinson's.

This will pave the way for more home genetic tests to go beyond providing ancestry info. And it's different than pharmacogenetic testing that tailors drugs and doses based on a patient's genes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote